Hormone treatment for prostate cancer. For people with prostate cancer, it may be confusing in choosing the best treatment procedure that can be done. Each treatment performed has its own risks and benefits. Treatment of prostate cancer depends on several factors:
- Stage of cancer
- Size of cancer
- Age and life expectancy of the patient
- How extensive the spread of cancer has occurred
- Patient health condition
For patients with prostate cancer at an early stage, they can choose to wait and monitor the development of cancer. There are some cases of prostate cancer that do not require treatment at all, and this needs to be considered because there are significant side effects of treatment.
When choosing to monitor prostate cancer, during the period of supervision, additional information may be collected to help determine the appropriate treatment.
This prostate control requires that you undergo a PSA test as well as biopsy procedures regularly. This is done to ensure as early as possible whether there is a growth of cancer cells. This series of procedures are performed to determine treatment in accordance with the stage of cancer suffered, especially when prostate cancer has spread out from the prostate gland.
hormone treatment for prostate cancer is to lower levels of male hormones (androgens), because of this androgen hormones make prostate cancer cells grow and develop. The main source of the body that produces androgen hormones comes from the testes.
Hormone treatment for prostate cancer
By lowering, androgen levels will make the prostate cancer becomes smaller or the growth becomes longer. With therapeutic hormone testosterone therapy the growth of cancer cells can be controlled, but can not cure cancer itself.
It may be that your doctor recommends treatment, and usually, the doctor can only control prostate cancer that has spread to other parts of the body with hormone therapy.
The results within a certain period of cancer will not grow, even years, but a small prostate cancer is growing even though there is no androgen hormone in men.
After performing orchiectomy treatment or treatment with LH RH agonist, the body will not produce testosterone produced by the testes. However, the adrenal glands still produce a small proportion of male hormones.
LH-RH (Luteinizing hormone-releasing hormone) agonists is a therapy that will stop the testicles from producing testosterone by preventing the mucous glands releasing hormones that can stimulate the production of the testoren.
So, within three or four months some types of drugs will be injected, or one year, depending on the type of injection the patient receives.
Hormone therapy is often used in the treatment of prostate cancer, if:
- No surgery or radiation for cancer treatment.
- Men who are at high risk for recurrence usually coincide with radiotherapy.
- Prostate cancer has spread to other organs or in cases of frequent cancer relapse.
- Used prior to surgery or radiotherapy in order to minimize cancer.
The use of drugs for hormone treatment for prostate cancer, among others,
- Luteinizing hormone agonists – hormone released (LHRH): this drug can prevent testes making testosterone. Is leuprolide and goserelin.
- Antiandrogens: These drugs can block the action of male hormones. Examples are flutamide, bicalutamide, and nilutamide.
- Other drugs: some drugs can prevent the adrenal glands from making testosterone. Is ketoconazole and aminoglutethimide.
Side effects of hormone therapy in prostate cancer are:
- Loss of sexual desire
- Erectile dysfunction or impotence
- Weight gain
- Swelling of the chest
- Hot flush or a condition in which the body suddenly feels too hot to cause excessive sweating and body shivering.